Table 5.
Role of PNPLA3 rs738409 as a moderator between dietary factors and fibrosis severity. Conditional effects of the dietary factors at values of the moderator using a dominant genetic model.
| Bootstrapped estimates (n=10,000) | Bootstrapped estimates (n=10,000) | |||||||
|---|---|---|---|---|---|---|---|---|
| Dietary factors | Unadjusted β coefficients (conditional effects) † |
Standard errors |
95% confidence intervals |
P value | Adjusted β coefficients (conditional effects) † |
Standard errors |
95% confidence intervals |
P value |
| Significant fibrosis (F≥2) | ||||||||
| Carbohydrate (% of energy) | ||||||||
| PNPLA3-CC | 0.009 | 0.021 | −0.033 to 0.050 | .679 | 0.027 | 0.023 | −0.018 to 0.073 | .239 |
| PNPLA3-GC+GG | 0.025 | 0.013 | 0.000 to 0.051 | .054 | 0.034 | 0.014 | 0.006 to 0.062 | .018 |
| n-3 PUFAs (g/day) ‡ | ||||||||
| PNPLA3-CC | −0.030 | 0.520 | −1.049 to 0.989 | .954 | −0.239 | 0.684 | −2.579 to 0.102 | .070 |
| PNPLA3-GC+GG | −0.694 | 0.317 | −1.315 to −0.074 | .028 | −1.844 | 0.540 | −2.902 to −0.786 | .001 |
| Total isoflavones (mg/day) ‡ | ||||||||
| PNPLA3-CC | 0.227 | 0.306 | −0.373 to 0.826 | .458 | 0.313 | 0.350 | −0.373 to 0.999 | .371 |
| PNPLA3-GC+GG | −0.429 | 0.154 | −0.731 to −0.126 | .005 | −0.453 | 0.184 | −0.814 to −0.092 | .014 |
| Methionine (mg/day) ‡ | ||||||||
| PNPLA3-CC | 0.092 | 0.382 | −0.657 to 0.840 | .810 | −0.741 | 0.514 | −1.748 to 0.266 | .149 |
| PNPLA3-GC+GG | −0.448 | 0.211 | −0.862 to −0.034 | .034 | −1.210 | 0.378 | −1.950 to −0.469 | .001 |
| Total choline (mg/d) ‡ | ||||||||
| PNPLA3-CC | 0.122 | 0.385 | −0.634 to 0.877 | .316 | −0.729 | 0.514 | −1.736 to 0.279 | .156 |
| PNPLA3-GC+GG | −0.402 | 0.233 | −0.859 to 0.054 | .084 | −1.231 | 0.413 | −2.040 to −0.422 | .003 |
| Overall fibrosis severity (stages 0-4) | ||||||||
| Carbohydrate (% of energy) | ||||||||
| PNPLA3-CC | 0.018 | 0.013 | −0.008 to 0.044 | .164 | 0.025 | 0.012 | 0.005 to 0.053 | .020 |
| PNPLA3-GC+GG | 0.021 | 0.008 | 0.005 to 0.038 | .011 | 0.029 | 0.008 | 0.010 to 0.041 | .001 |
| n-3 PUFAs (g/day) ‡ | ||||||||
| PNPLA3-CC | −0.105 | 0.328 | −0.750 to 0.539 | .749 | −0.813 | 0.366 | −1.533 to −0.093 | .027 |
| PNPLA3-GC+GG | −0.521 | 0.199 | −0.913 to −0.130 | .009 | −1.176 | 0.293 | −1.752 to −0.600 | <.001 |
| Total isoflavones (mg/day) ‡ | ||||||||
| PNPLA3-CC | 0.097 | 0.192 | −0.281 to 0.475 | .614 | 0.138 | 0.190 | −0.234 to 0.511 | .466 |
| PNPLA3-GC+GG | −0.283 | 0.089 | −0.458 to −0.108 | .002 | −0.253 | 0.095 | −0.440 to −0.067 | .008 |
| Methionine (mg/day) ‡ | ||||||||
| PNPLA3-CC | 0.011 | 0.240 | −0.461 to 0.484 | .962 | −0.523 | 0.277 | −1.067 to 0.022 | .060 |
| PNPLA3-GC+GG | −0.364 | 0.133 | −0.625 to −0.103 | .006 | −0.824 | 0.205 | −1.228 to −0.421 | <.001 |
| Total choline (mg/d) ‡ | ||||||||
| PNPLA3-CC | 0.040 | 0.243 | −0.437 to 0.517 | .869 | −0.518 | 0.278 | −1.064 to 0.028 | .063 |
| PNPLA3-GC+GG | −0.353 | 0.148 | −0.643 to −0.063 | .017 | -−0.864 | 0.224 | −1.304 to −0.425 | <.001 |
Abbreviations: PNPLA3, patatin-like phospholipase domain-containing 3; PUFAs, polyunsaturated fatty acids.
Conditional or moderation effects were calculated while adjusting for age, gender, type 2 diabetes, BMI (kg/m2) and calorie intake (kcal).
Log-transformed variables.